Hikma Pharmaceuticals PLC | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
241.42 M |
Public Float |
- |
Hikma Pharmaceuticals PLC | |
Stock Exchange | London Stock Exchange |
EPS |
GBP0.88 |
Market Cap |
GBP4.28 B |
Shares Outstanding |
241.42 M |
Public Float |
137.42 M |
Address |
1 New Burlington Place London Greater London W1S 2HR United Kingdom |
Employees | - |
Website | http://hikma.com |
Updated | 07/08/2019 |
Hikma Pharmaceuticals Plc engages in developing, manufacturing, and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics, and Others. The Branded segment offers selling of branded generics and in-licensed patented products. |